Analyst picks & changes

Genzyme Corp.

Data from Genzyme Corp.'s Phase III study of


recombinant thyroid stimulating hormone provoked divergent interpretations among analysts.

Meirav Chovav of Salomon Brothers said that based on the data (see

Read the full 320 word article

How to gain access

Continue reading with a
two-week free trial.